from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv2050/-

LFCtreatmentdescriptionclass of inhibitor

2.277

Amikacinug/mL Amikacintranslation

1.885

Cap5-10ug/mL Capreomycintranslation

2.802

Rox10-50 ug/mL Roxithromycintranslation

1.369

SM2-5 ug/mL Streptomycintranslation

1.826

Tet5-10 ug/mL Tetracyclinetranslation

-0.747

Rif0.2-5ug/mL Rifampicintranscription

-0.211

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.205

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.363

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

0.607

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.208

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.741

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

0.372

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-0.753

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

-0.672

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.231

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.228

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

1.117

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-1.101

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.190

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.915

KCN5-20 ug/mL Potassium cyaniderespiration

-0.685

NaN30.2-2 mM Sodium aziderespiration

0.896

Nigericin50 uM Nigericinrespiration

-0.861

TRC10-150 ug/mL Triclosanrespiration

2.169

TRZ10-25 ug/mL Thioridazinerespiration

2.146

Valinomycin0.5-10 uM Valinomycinrespiration

0.329

ZnSO42 mM ZnSO4respiration

1.896

menadione6-10 ug/mL Menadionerespiration

0.000

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.455

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.307

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.477

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

1.273

NRP_1Non-replicating persistence stage 1dosRassociated

-0.145

Amp0.2mg/mL AmpicillincellWall

-0.100

Cephalexin20-100 ug/mL CephalexincellWall

0.414

Cerulenin0.32-5 ug/mL CerulenincellWall

-0.415

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.516

EMB10-20 ug/mL EthambutolcellWall

0.310

Eta12-40 ug/mL EthionamidecellWall

0.231

INH0.2-0.4 ug/mL IsoniazidcellWall

0.150

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.906

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.031

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.332

BZA0.12 mg/mL BenzamidearomaticAmides

-0.276

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

0.317

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.319

H2O24 mM hydrogen peroxideDNAdamaging

-0.265

Levo10 ug/mL LevofloxacinDNAdamaging

-0.396

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.351

Novobiocin10 ug/mL NovobiocinDNAdamaging

-0.083

Oflox5-10 ug/mL OfloxacinDNAdamaging

-0.327

UVUV-irradiationDNAdamaging

1.406

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.624

Antimycin12.5-50 ug/mL Antimycin A?

-0.558

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.994

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.549

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.479

PA8240.2-2 ug/mL PA-824?

-0.546

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

-0.784

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.173

Verapamil50 uM Verapamil?

-0.517

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.595

methoxatin10-20 ug/mL Methoxatin?